# Pilot Study of Ketamine Sedation for Aneurysmal Subarachnoid Hemorrhage

> **NCT05032118** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Jenna L Leclerc MD, PhD**

## Conditions studied

- Subarachnoid Hemorrhage, Aneurysmal

## Interventions

- **DRUG:** Ketamine Hydrochloride
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT05032118
- **Lead sponsor:** Jenna L Leclerc MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-04-27
- **Primary completion:** 2023-04-27
- **Final completion:** 2023-04-27
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Institution change, no IRB approval
- **Last updated:** 2023-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05032118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05032118, "Pilot Study of Ketamine Sedation for Aneurysmal Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05032118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*